Gabapentin Extends Glioblastoma Patient Survival

Senses, Attention, and Deep Brain Hubs

A recent study using fMRI data found that all human senses activate the same deep brain regions, specifically the midbrain reticular formation and central thalamus, when a person is sharply focused. This surprising discovery indicates a shared subcortical network for sensory attention, regardless of the type of sensory input received. This research advances our understanding of how the brain organizes consciousness and could potentially lead to new treatments for conditions impacting attention and awareness. https://neurosciencenews.com/sensory-neuroscience-consciousness-28938/

Silent Impact of Recessive Genes

According to recent research, carriers of recessive gene mutations, even with only one affected copy, may face subtle health challenges and reduced reproductive success, contradicting traditional understanding. A study of over 300,000 people suggests that individuals carrying recessive genes for intellectual disability are particularly affected, exhibiting shorter educational paths and a higher likelihood of remaining childless. These findings challenge existing genetic theories and imply that both natural and sexual selection continue to influence the human genome through these seemingly silent gene variations. The research posits that while the majority of intellectual disabilities arise from spontaneous mutations, the absence of expected recessive mutations in the population points to evolutionary pressures acting against carriers.https://neurosciencenews.com/recessive-genes-evolution-neurosciencce-28937/

Gabapentin Extends Glioblastoma Patient Survival

Based on analyses from over 1,000 patients at two medical centers, a new study from Mass General Brigham suggests that the common medication gabapentin is associated with improved survival rates in individuals diagnosed with glioblastoma (GBM), the most aggressive type of brain cancer. The research indicates that gabapentin use was linked to an average of 4 to 6 months longer survival and may work by reducing levels of the protein TSP-1, which is known to promote tumor growth. While these retrospective findings are considered promising, further randomized clinical trials are necessary to confirm gabapentin's therapeutic potential for GBM patients. https://neurosciencenews.com/gabapentin-glioblastoma-cancer-28936/

Bioenergetic Age_ A New Key to Alzheimer's Risk and Prevention

According to new research, a person's bioenergetic age, a measure of cellular energy efficiency, is a strong predictor of Alzheimer's disease risk and progression. Higher levels of specific molecules called acylcarnitines in the blood are linked to faster cognitive decline and more severe Alzheimer's symptoms, indicating an older bioenergetic age. However, lifestyle choices, such as adopting plant-based diets and engaging in regular exercise, can help lower acylcarnitine levels, effectively reducing bioenergetic age. This suggests that lifestyle interventions may offer personalized prevention strategies for Alzheimer's, potentially as effectively as some medications, especially for individuals with certain genetic predispositions but favorable bioenergetic profiles. This research also suggests a potential for using existing blood tests to assess bioenergetic age for earlier risk identification. https://neurosciencenews.com/bioenergetic-age-alzheimers-28486/

Dopamine Rewires Reward Memories_ A New Role Discovered

Research out of Michigan State University indicates that dopamine, a neurochemical, plays an unexpected role in how the brain processes memories associated with positive experiences. A study involving mice demonstrated that dopamine can actively decrease the perceived value of a rewarding memory, even if the reward itself did not cause a negative outcome. This process of memory devaluation was sufficient to alter future behavior in the mice, influencing their choices about seeking out the reward. These findings expand the current understanding of dopamine's functions and suggest potential new avenues for developing treatments for conditions linked to problematic reward-related memories, such as addiction and certain psychiatric disorders. https://neurosciencenews.com/dopamine-reward-memory-28487/